NCT07458113 2026-03-09
BERLIN
Yale University
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT07454668 2026-03-06
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Baptist Health South Florida
Phase 1 Not yet recruiting
NCT07177950 2025-09-17
A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases
Peking University Cancer Hospital & Institute
Phase 1/2 Not yet recruiting
NCT06611306 2024-10-15
BEAT-Breast
Imperial College London
Phase NA Not yet recruiting
NCT06462079 2024-06-17
Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases
Guangzhou Medical University
Phase 2 Not yet recruiting
NCT06088056 2023-10-18
A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases
Fudan University
Phase 2 Not yet recruiting